In the Tat peptide- and Control-SH3GL2-treated groups, PSD95 protein levels gradually decreased 1 day and 4 days after ischemia, while synaptophysin and SNAP-25 levels increased 4 days after ischemia. This evidence concerns the gene SH3GL2 and ischemia.